162
Views
9
CrossRef citations to date
0
Altmetric
Articles

Neurotrophin system activation in pleural effusions

, , , , , , , , , , , , , & show all
Pages 221-231 | Received 25 Nov 2009, Accepted 03 Feb 2010, Published online: 10 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alberto Ricci*Claudia De Vitis*Alessia Noto*Luigi Fattore, Salvatore Mariotta, Emanuela Cherubini, Giuseppe Roscilli, Giuseppina Liguori, Giosuè Scognamiglio, Gaetano Rocco, Gerardo Botti, Enrico Giarnieri, Maria Rosaria Giovagnoli, Giorgio De Toma, Gennaro Ciliberto & Rita Mancini. (2013) TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung. Cell Cycle 12:11, pages 1696-1703.
Read now

Articles from other publishers (8)

Patrick Smeele, Sènan Mickaël d’Almeida, Clément Meiller, Anne-Laure Chéné, Charly Liddell, Laurent Cellerin, François Montagne, Sophie Deshayes, Sarah Benziane, Marie-Christine Copin, Paul Hofman, Françoise Le Pimpec-Barthes, Henri Porte, Arnaud Scherpereel, Marc Grégoire, Didier Jean & Christophe Blanquart. (2018) Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis. Molecular Cancer 17:1.
Crossref
Elena Pompili, Cinzia Fabrizi, Francesca Somma, Virginia Correani, Bruno Maras, Maria Eugenia Schininà, Viviana Ciraci, Marco Artico, Francesco Fornai & Lorenzo Fumagalli. (2017) PAR1 activation affects the neurotrophic properties of Schwann cells. Molecular and Cellular Neuroscience 79, pages 23-33.
Crossref
Valérie Chopin, Chann Lagadec, Robert-Alain Toillon & Xuefen Le Bourhis. (2016) Neurotrophin signaling in cancer stem cells. Cellular and Molecular Life Sciences 73:9, pages 1859-1870.
Crossref
B T Paul, Z Blanchard, M Ridgway & W M ElShamy. (2014) BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin. Oncogene 34:23, pages 3036-3052.
Crossref
Ombretta Melaiu, Alfonso Cristaudo, Erika Melissari, Manuela Di Russo, Alessandra Bonotti, Rossella Bruno, Rudy Foddis, Federica Gemignani, Silvia Pellegrini & Stefano Landi. (2012) A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma. Mutation Research/Reviews in Mutation Research 750:2, pages 132-140.
Crossref
Rita Mancini, Enrico Giarnieri, Claudia De Vitis, Donatella Malanga, Giuseppe Roscilli, Alessia Noto, Emanuele Marra, Carmelo Laudanna, Pietro Zoppoli, Pasquale De Luca, Andrea Affuso, Luigi Ruco, Arianna Di Napoli, Giuseppe Mesiti, Luigi Aurisicchio, Alberto Ricci, Salvatore Mariotta, Lara Pisani, Claudio Andreetti, Giuseppe Viglietto, Erino A. Rendina, Maria Rosaria Giovagnoli & Gennaro Ciliberto. (2011) Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment. PLoS ONE 6:7, pages e21320.
Crossref
Taishi Harada, Yasushi Yatabe, Masafumi Takeshita, Takaomi Koga, Tokujiro Yano, Yisong Wang & Giuseppe Giaccone. (2011) Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer. Clinical Cancer Research 17:9, pages 2638-2645.
Crossref
BERNARD C. DUYSINX, ASTRID PAULUS, VINCENT HEINEN, DELPHINE NGUYEN, MONIQUE HENKET, JEAN-LOUIS CORHAY & RENAUD LOUIS. (2011) Diagnostic value of neurotrophin expression in malignant pleural effusions. Experimental and Therapeutic Medicine 2:5, pages 941-946.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.